1.
Diagn Microbiol Infect Dis
; 95(4): 114875, 2019 Dec.
Article
in English
| MEDLINE
| ID: mdl-31474463
ABSTRACT
This study aimed to follow the trend of primary antimicrobial resistance in Helicobacter pylori isolates obtained from several centers in Brussels. We observed increasing rates of primary resistance to macrolides (10.5% to 18%) to nitro-imidazoles (28% to 40%) and to fluoroquinolones (12.4% to 22.8%), respectively, from 2008/2009 to 2016.